A complete application in a minute
Tailored resume and cover letter, ready to send.
ETH Zurich in Basel invites exceptional candidates for a Postdoctoral position in the Biotechnology and Bioengineering group led by Prof. Dr. Martin Fussenegger.
The project sits at the intersection of synthetic biology, nanotechnology, and bioelectronics, aiming to engineer programmable cells for wireless, real‑time control of therapeutic protein expression. You will collaborate across physics, chemistry and biology, contribute to bioelectronic implant concepts, and develop computational models
A World-Class Research Environment at the Nexus of Biology, Engineering, and Physical Sciences
The Biotechnology and Bioengineering group led by Prof. Dr. Martin Fussenegger at the Department of Biosystems Science and Engineering (D-BSSE) of ETH Zurich in Basel invites exceptional candidates to apply for a Postdoc position in pioneering projects at the intersection of synthetic biology, nanotechnology, and bioelectronics.
The D-BSSE is ETH Zurich's first truly interdisciplinary research department uniting theoretical and experimental biology with advanced bioengineering and fostering close collaborations with leaders in materials science, physics, and chemistry to drive transformative advances in systems biology, biotechnology, and synthetic biology. Situated in Basel, Switzerland, at the heart of the BioValley, a tri-national region that hosts 40% of the global life sciences industry and numerous major pharmaceutical companies, the D-BSSE offers a unique environment for high-impact translational research with unparalleled access to academic and industrial expertise.
Advancing the Frontiers of Bioelectronics and Synthetic Biology
Our group integrates state-of-the-art synthetic biology with advanced nanotechnology, and electrogenetic interfaces to engineer human cells for next generation bioelectronic medicine, designing programmable cells that respond to electrical, electromagnetic, acoustic and biochemical cues to achieve wireless, real-time control of therapeutic protein expression and metabolic regulation. Leveraging innovative platforms such as direct-current-actuated regulation, electromagnetic programming of wireless expression, and closed-loop systems, we aim to translate these technologies into clinically relevant, minimally invasive therapies for cancer, as well as metabolic, neurodegenerative, autoimmune, and infectious diseases.
chevron_right Working, teaching and research at ETH Zurich
In line with our values, ETH Zurich encourages an inclusive culture. We promote equality of opportunity, value diversity and nurture a working and learning environment in which the rights and dignity of all our staff and students are respected. Visit our Equal Opportunities and Diversity website to find out how we ensure a fair and open environment that allows everyone to grow and flourish. Sustainability is a core value for us – we are consistently working towards a climate-neutral future.